Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with increasing age, being a major component in the development of frailty. Current knowledge on its assessment, etiology, pathogenesis, consequences and future perspectives are reported in the present review. On-going and future clinical trials on sarcopenia may radically change our preventive and therapeutic approaches of mobility disability in older people.
Sarcopenia : its assessment, etiology, pathogenesis, consequences and future perspectives / Y. Rolland, S. Czerwinski, G. Abellan Van Kan, J.E. Morley, M. Cesari, G. Onder, J. Woo, R. Baumgartner, F. Pillard, Y. Boirie, W.M.C. Chumlea, B. Vellas. - In: THE JOURNAL OF NUTRITION, HEALTH & AGING. - ISSN 1279-7707. - 12:7(2008), pp. 433-450.
Sarcopenia : its assessment, etiology, pathogenesis, consequences and future perspectives
M. Cesari;
2008
Abstract
Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with increasing age, being a major component in the development of frailty. Current knowledge on its assessment, etiology, pathogenesis, consequences and future perspectives are reported in the present review. On-going and future clinical trials on sarcopenia may radically change our preventive and therapeutic approaches of mobility disability in older people.File | Dimensione | Formato | |
---|---|---|---|
Sarcopenia- its assessment, etiology, pathogenesis, consequences and future perspectives - Rolland et al. (2008).pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
614.47 kB
Formato
Adobe PDF
|
614.47 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.